Passage Bio Inc
NASDAQ:PASG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Passage Bio Inc
NASDAQ:PASG
|
US |
|
P
|
Pfizer Inc
SIX:PFE
|
US |
|
H
|
Hikari Tsushin Inc
DUS:HIK
|
JP |
|
PepsiCo Inc
NASDAQ:PEP
|
US |
|
T
|
Taiwan Semiconductor Manufacturing Co Ltd
SWB:TSFA
|
TW |
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
S
|
Steelcase Inc
F:GJB
|
US |
|
Vivoryon Therapeutics NV
F:05Y
|
DE |
|
Avi Ltd
F:IZ6
|
ZA |
|
V
|
Vornado Realty Trust
F:VO7
|
US |
|
C
|
Callaway Golf Co
F:CLY
|
US |
|
C
|
Covivio SA
SWB:F5D
|
FR |
|
W
|
Weichai Power Co Ltd
XHAM:WI4
|
CN |
Wall St Price Targets
PASG Price Targets Summary
Passage Bio Inc
According to Wall Street analysts, the average 1-year price target for
PASG is 15.81 USD with a low forecast of 8.08 USD and a high forecast of 24.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PASG's stock price target?
Price Target
15.81
USD
According to Wall Street analysts, the average 1-year price target for
PASG is 15.81 USD with a low forecast of 8.08 USD and a high forecast of 24.15 USD.